Apmonia Therapeutics is looking for a highly challenging role at Director level to drive the R&D department, with a focus on oncology and extracellular matrix targeting using peptides/small molecules.
Apmonia Therapeutics is a biotechnology company developing a pipeline of immunotherapy strategies for solid tumors by modulating multiple aspects of tumor microenvironment. Its most advanced technology is intended to target tumors expressing matricellular protein thrombospondin-1 (TSP-1).
Apmonia Therapeutics is looking for an experienced professional with a strong background in oncology, early-stage development, and small molecules/peptides. Selected candidate will play a crucial part in the development of the R&D department both on a strategic and scientific level.
Please send CV, publication track record, motivation letter and names of referee(s) to